Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Transdiagnostic prevention in youth mental health, Part I: rationale, shared risk factors
    Published on 2025-10-02
    10 months ago
  • Inflammatory mechanisms contribute to long-term cognitive deficits induced by perinatal asphyxia via interleukin-1
    Published on 2025-10-02
    10 months ago
  • From symptom-based heterogeneity to mechanism-based profiling in youth ADHD: the promise of computational psychiatry
    Published on 2025-09-30
    10 months ago
  • Digital frontlines: leveraging AI to augment human expertise in crisis and combat situations
    Published on 2025-09-29
    10 months ago
  • Dorsomedial striatal neuroinflammation causes excessive goal-directed action control by disrupting astrocyte function
    Published on 2025-09-27
    10 months ago
  • In Memoriam: Terry A. Ketter, MD
    Published on 2025-09-26
    10 months ago
  • A review of the impact of structural racism on lived experiences of adolescents of African descent: Implications for development, brain structure, and health
    Published on 2025-09-26
    10 months ago
« Previous 1 … 36 37 38 39 40 … 143 Next »
Journal of Psychopharmacology
  • Associations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort study
    Published on 2025-01-02
    2 years ago
  • Brain serotonin, oxytocin, and their interaction: Relevance for eating disorders
    Published on 2025-01-02
    2 years ago
  • Commentary: A framework for assessment of adverse events in psychedelic research
    Published on 2024-12-30
    2 years ago
  • A reflection on paradigmatic tensions within the FDA advisory committee for MDMA-assisted therapy
    Published on 2024-12-27
    2 years ago
  • Hemispheric annealing and lateralization under psychedelics (HEALS): A novel hypothesis of psychedelic action in the brain
    Published on 2024-12-20
    2 years ago
  • Navigating agitation in neurodevelopmental disorders: A comparative study of pharmacotherapies via network meta-analysis in children and adults with autism spectrum disorder or intellectual disabilities
    Published on 2024-12-18
    2 years ago
  • Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature
    Published on 2024-12-17
    2 years ago
« Previous 1 … 36 37 38 39 40 … 150 Next »
European Neuropsychopharmacology
  • Optimizing differential diagnostics and identifying transdiagnostic treatment targets using virtual reality
    Published on 2024-11-29
    2 years ago
  • Association between genetic risk of attention deficit hyperactivity disorder and trajectories of daily gaming time in children
    Published on 2024-11-29
    2 years ago
  • Corrigendum to “Lung function decline in people with serious mental illness: A call to action” [European Neuropsychopharmacology (2024) 41-46/ ENP-24-342]
    Published on 2024-11-22
    2 years ago
  • The need for specific mental health interventions for the prevention of suicide in postpandemic times
    Published on 2024-11-15
    2 years ago
  • Therapeutic potential of minor cannabinoids in psychiatric disorders: A systematic review
    Published on 2024-11-14
    2 years ago
  • Excess mortality and life-years lost in people diagnosed with depression: A 20-year population-based cohort study of 126,573 depressed individuals followed for 1,139,073 persons-years
    Published on 2024-11-12
    2 years ago
  • Environmentally conscious psychopharmacotherapy: Practice recommendations for psychiatrists
    Published on 2024-11-12
    2 years ago
« Previous 1 … 36 37 38 39 40 … 168 Next »

   Pharma Pub